Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.450
-0.080 (-2.27%)
Mar 5, 2026, 9:23 AM CET
Scandinavian ChemoTech AB Revenue
In the year 2025, Scandinavian ChemoTech AB had annual revenue of 12.29M SEK with 87.10% growth. Scandinavian ChemoTech AB had revenue of 2.65M in the quarter ending December 31, 2025, with 29.74% growth.
Revenue
12.29M
Revenue Growth
+87.10%
P/S Ratio
7.31
Revenue / Employee
12.29M
Employees
1
Market Cap
89.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.29M | 5.72M | 87.10% |
| Dec 31, 2024 | 6.57M | 3.74M | 132.67% |
| Dec 31, 2023 | 2.82M | 2.35M | 496.62% |
| Dec 31, 2022 | 473.00K | -2.11M | -81.70% |
| Dec 31, 2021 | 2.59M | 1.17M | 82.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xbrane Biopharma AB | 152.35M |
| IRLAB Therapeutics AB | 57.46M |
| Alzinova AB | 26.12M |
| Biovica International AB | 9.89M |
| Spago Nanomedical AB | 4.82M |
| Alligator Bioscience AB | 4.42M |
| Simris Group AB (PUBL) | 3.40M |
| OncoZenge AB | 2.78M |